Increase in government support for management of liver diseases is the major driver of the global transjugular intrahepatic portosystemic shunt (TIPS) market.
”
— Allied Market Research
WILMINGTON, DELAWARE , UNITED STATES, June 6, 2024 /EINPresswire.com/ — The transjugular intrahepatic portosystemic shunt (TIPS) market size was valued at $93.4 million in 2021, and is estimated to reach $127.9 million by 2031, growing at a CAGR of 3.2% from 2022 to 2031.
A shunt (tube) called a transjugular intrahepatic portosystemic shunt (TIPS) is positioned between the hepatic vein, which transports blood from the liver to the vena cava and heart, and the portal vein, which transports blood from the intestines/spleen to the liver. TIPS is mostly used on patients with cirrhosis, a condition in which the liver’s scar tissue partially obstructs the blood’s path from the portal vein to the hepatic vein. and a tract is subsequently constructed to the portal vein’s intrahepatic section.A significant development in the management of portal hypertension is the transjugular intrahepatic portosystemic shunt. Additionally, it is used to treat Budd-Chirai syndrome and hepatorenal syndrome. TIPS is the hemodynamic counterpart of a surgical shunt with a narrow diameter placed side to side. A stent is positioned between the portal vein and the hepatic vein to construct the actual shunt. The TIPS stent is inserted using aseptic approach in interventional radiology. The right internal jugular vein is used in this technique to send a needle catheter to the hepatic vein, from which a tract is formed to the intrahepatic section of the portal vein.
The development of new TIPS devices by numerous key players, coupled with an increase in the risk of organ failure and an increase in the prevalence of liver diseases such as hepatorenal syndrome, Budd-Chirai Syndrome, and portal hypertension, are driving factors behind the growth of the global transjugular intrahepatic portosystemic shunt market. In addition, the growing number of elderly people experiencing portal vein thrombosis and other liver illnesses, together with the increased need for TIPS surgery as a result of the organ donor scarcity, are contributing factors to the market expansion. of the upcoming years, there will be more chances due to the increase of product approvals.
𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/A31429
𝐓𝐡𝐞 𝐩𝐨𝐫𝐭𝐚𝐥 𝐡𝐲𝐩𝐞𝐫𝐭𝐞𝐧𝐬𝐢𝐨𝐧 𝐬𝐞𝐠𝐦𝐞𝐧𝐭 𝐭𝐨 𝐜𝐨𝐧𝐭𝐢𝐧𝐮𝐞 𝐢𝐭𝐬 𝐥𝐞𝐚𝐝𝐞𝐫𝐬𝐡𝐢𝐩 𝐬𝐭𝐚𝐭𝐮𝐬 𝐭𝐡𝐫𝐨𝐮𝐠𝐡𝐨𝐮𝐭 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝
In terms of application, the portal hypertension segment accounted for over four-fifths of the global transjugular intrahepatic portosystemic shunt market in 2021 and is expected to maintain its lead position in terms of revenue throughout the duration of the projection. Furthermore, it is predicted that between 2022 and 2031, this market will grow at the fastest rate, 3.3%. The growth in the number of portal hypertension cases and the rise in patient demand for transjugular intrahepatic portosystemic shunts (TIPS) are the reasons for this. The segments on Budd Chiari Syndrome and other topics are also included in the report.
𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 𝐭𝐨 𝐜𝐨𝐧𝐭𝐢𝐧𝐮𝐞 𝐢𝐭𝐬 𝐝𝐨𝐦𝐢𝐧𝐚𝐧𝐭 𝐬𝐡𝐚𝐫𝐞 𝐭𝐡𝐫𝐨𝐮𝐠𝐡𝐨𝐮𝐭 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝
With almost two-fifths of the global transjugular intrahepatic portosystemic shunt market, North America led the market by geography in 2021 and is expected to maintain its leading share for the duration of the forecast period. This is explained by an increase in liver procedures, the presence of important figures, the growth of the healthcare industry, and the availability of cutting-edge TIPS devices in the area. However, due to the expansion of leading market participants’ presence throughout the area, the development of healthcare infrastructure, and the rise in lifetime support use, Asia-Pacific is predicted to experience the fastest compound annual growth rate (CAGR) of 5.0% from 2022 to 2031. The study also examines regions such as LAMEA and Europe.
𝐊𝐄𝐘 𝐅𝐈𝐍𝐃𝐈𝐍𝐆𝐒 𝐎𝐅 𝐓𝐇𝐄 𝐒𝐓𝐔𝐃𝐘
The study provides an in-depth transjugular intrahepatic portosystemic shunt (TIPS) market analysis, and the future estimations to elucidate imminent investment pockets & current transjugular intrahepatic portosystemic shunt (TIPS) market trends.
By device type, the stents segment held largest market share in 2021, and is expected to remain dominant throughout the transjugular intrahepatic portosystemic shunt (TIPS) market forecast.
By application, the portal hypertension segment held largest market share in 2021, and is expected to remain dominant throughout the forecast period
By end user, the hospitals segment dominates the global market in 2021, and is anticipated to continue this trend during the forecast period.
By region, Asia-Pacific is expected to experience growth at the highest rate during the forecast period.
𝐃𝐨 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐄𝐧𝐪𝐮𝐢𝐫𝐲 𝐭𝐨 𝐊𝐧𝐨𝐰 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 https://www.alliedmarketresearch.com/purchase-enquiry/A31429
𝐊𝐞𝐲 𝐁𝐞𝐧𝐞𝐟𝐢𝐭𝐬 𝐅𝐨𝐫 𝐒𝐭𝐚𝐤𝐞𝐡𝐨𝐥𝐝𝐞𝐫𝐬
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the transjugular intrahepatic portosystemic shunt (TIPS) market analysis from 2021 to 2031 to identify the prevailing transjugular intrahepatic portosystemic shunt (TIPS) market opportunity.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the transjugular intrahepatic portosystemic shunt (tips) market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global transjugular intrahepatic portosystemic shunt (tips) market trends, key players, market segments, application areas, and market growth strategies.
𝐋𝐞𝐚𝐝𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐏𝐥𝐚𝐲𝐞𝐫𝐬
Boston Scientific Corporation
Becton, Dickinson and Company
Angiodynamics, Inc.
Cook Medical, Inc.
Neuromedex GmbH
W.L Gore & Associates, Inc.
Terumo Medical Corporation
𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 (𝐁𝐨𝐨𝐤 𝐍𝐨𝐰 𝐰𝐢𝐭𝐡 𝟏𝟎% 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭):
𝐒𝐮𝐫𝐠𝐢𝐜𝐚𝐥 𝐂𝐥𝐚𝐦𝐩𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/surgical-clamps-market-A13381
𝐏𝐢𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐃𝐢𝐬𝐨𝐫𝐝𝐞𝐫 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/pigmentation-disorder-treatment-market-A11229
𝐕𝐞𝐭𝐞𝐫𝐢𝐧𝐚𝐫𝐲 𝐎𝐧𝐜𝐨𝐥𝐨𝐠𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/veterinary-oncology-market-A07139
David Correa
Allied Market Research
+ 18007925285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Article originally published on www.einpresswire.com as Asia-Pacific to Grow at the Highest Rate During 2021-2031
